Know Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% – Time to Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW)’s stock price rose 3.8% during mid-day trading on Friday . The stock traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares changed hands during trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Stock Up 3.8%

The stock has a market cap of $16.04 million, a PE ratio of -0.33 and a beta of 1.83. The firm has a 50-day simple moving average of $2.14 and a 200-day simple moving average of $2.14.

Institutional Investors Weigh In On Know Labs

A hedge fund recently bought a new stake in Know Labs stock. Cerity Partners LLC bought a new position in shares of Know Labs, Inc. (NYSEAMERICAN:KNW) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 80,000 shares of the company’s stock, valued at approximately $158,000. Cerity Partners LLC owned approximately 1.07% of Know Labs at the end of the most recent reporting period. Hedge funds and other institutional investors own 23.96% of the company’s stock.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.